DCM
Driehaus Capital Management Portfolio holdings
AUM
$12.5B
1-Year Return
79.21%
This Quarter Return
-1.9%
1 Year Return
+79.21%
3 Year Return
+526.69%
5 Year Return
+1,716.36%
10 Year Return
+17,720.68%
AUM
$10.4B
AUM Growth
-$1.74B
(-14%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-4.51%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
476
New
95
Increased
124
Reduced
143
Closed
82
Top Buys
| 1 |
Guardant Health
GH
|
+$82.3M |
| 2 |
Sea Limited
SE
|
+$80.3M |
| 3 |
Elastic
ESTC
|
+$73.4M |
| 4 |
EXL Service
EXLS
|
+$57.7M |
| 5 |
BridgeBio Pharma
BBIO
|
+$51.9M |
Top Sells
| 1 |
Core Scientific
CORZ
|
+$144M |
| 2 |
Semtech
SMTC
|
+$126M |
| 3 |
Freshpet
FRPT
|
+$120M |
| 4 |
Modine Manufacturing
MOD
|
+$91.8M |
| 5 |
Credo Technology Group
CRDO
|
+$89.4M |
Sector Composition
| 1 | Healthcare | 24.7% |
| 2 | Technology | 18.5% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Financials | 11.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Soleno Therapeutics
SLNO
$3.11B
| $17.7M | 0.17% |
+247,737
| New | +$17.7M |
|
177
Reddit
RDDT
$47.3B
| $17.2M | 0.17% |
163,862
-10,406
| -6% | -$1.09M |
|
178
Exelixis
EXEL
$10.2B
| $17.1M | 0.17% |
463,949
+117,006
| +34% | +$4.32M |
|
179
Viridian Therapeutics
VRDN
$1.65B
| $17.1M | 0.17% |
1,270,481
-605,395
| -32% | -$8.16M |
|
180
Arcutis Biotherapeutics
ARQT
$2.1B
| $17.1M | 0.16% |
1,092,735
-4,034
| -0.4% | -$63.1K |
|
181
Payoneer
PAYO
$2.39B
| $17.1M | 0.16% |
2,337,504
+414,695
| +22% | +$3.03M |
|
182
Enovix
ENVX
$1.95B
| $17.1M | 0.16% |
2,655,557
+47,496
| +2% | +$305K |
|
183
Ligand Pharmaceuticals
LGND
$3.21B
| $17.1M | 0.16% |
162,170
-601
| -0.4% | -$63.2K |
|
184
Grid Dynamics Holdings
GDYN
$639M
| $16.9M | 0.16% |
1,080,536
+205,634
| +24% | +$3.22M |
|
185
Scholar Rock
SRRK
$2.92B
| $16.5M | 0.16% |
514,092
-1,913
| -0.4% | -$61.5K |
|
186
Burlington
BURL
$17.7B
| $16.4M | 0.16% |
68,797
-6,588
| -9% | -$1.57M |
|
187
AvePoint
AVPT
$3.42B
| $16.2M | 0.16% |
1,124,918
+106,513
| +10% | +$1.54M |
|
188
Adaptive Biotechnologies
ADPT
$1.96B
| $16M | 0.15% |
2,152,335
+1,306,164
| +154% | +$9.7M |
|
189
Grand Canyon Education
LOPE
$5.68B
| $15.8M | 0.15% |
+91,293
| New | +$15.8M |
|
190
Fair Isaac
FICO
$37.1B
| $15.8M | 0.15% |
8,550
+427
| +5% | +$787K |
|
|
CNTA
191
Centessa Pharmaceuticals
CNTA
$3.02B
| $15.8M | 0.15% |
1,095,533
-502,650
| -31% | -$7.23M |
|
192
Alnylam Pharmaceuticals
ALNY
$61.2B
| $15.4M | 0.15% |
57,128
+23,648
| +71% | +$6.39M |
|
193
American Superconductor
AMSC
$2.37B
| $15.2M | 0.15% |
839,843
-102,855
| -11% | -$1.87M |
|
194
SharkNinja
SN
$16.4B
| $15M | 0.14% |
179,483
-6,643
| -4% | -$554K |
|
195
iShares MSCI India Small-Cap ETF
SMIN
$930M
| $14.8M | 0.14% |
+217,174
| New | +$14.8M |
|
196
Blue Foundry Bancorp
BLFY
$196M
| $14.7M | 0.14% |
1,595,622
-112,154
| -7% | -$1.03M |
|
197
Atmus Filtration Technologies
ATMU
$3.74B
| $14.6M | 0.14% |
397,909
-1,478
| -0.4% | -$54.3K |
|
198
Acuity Brands
AYI
$10.1B
| $14.3M | 0.14% |
54,365
+17,061
| +46% | +$4.49M |
|
|
LB
199
LandBridge Company LLC
LB
$1.31B
| $14.1M | 0.14% |
195,500
-720
| -0.4% | -$51.8K |
|
200
Vital Farms
VITL
$2.11B
| $14M | 0.14% |
460,693
+91,580
| +25% | +$2.79M |
|